İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

ÇAĞDAŞ AKTAN

DOÇENT

BANDIRMA ONYEDİ EYLÜL ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 58
  • Proje 0
  • Kitap 0
  • Bildiri 48
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 21 Q2 12 Q3 11 Q4 5
WoS (JCR) Q1 6 Q2 23 Q3 3 Q4 16
TR Index 18 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 2
Üst %10 makale 9
Ort. yüzdelik 59.7%
Üst %1 payı 3.8%
Üst %10 payı 17.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 58 yayın

Scopus (SJR)
Q1 21 Q2 12 Q3 11 Q4 5
WoS (JCR)
Q1 6 Q2 23 Q3 3 Q4 16
TR Index
18 makale

Makale listesi

  1. 2025 Transcriptomic Profile of Perineural Invasion in Prostate Cancer Identifies Prognostic Gene Signatures Biomedicines DOI 10.3390/biomedicines13081789 YÖKSİS SJR Q1 JCR Q2 OpenAlex 87.2%
  2. 2025 Clinical Outcomes and Genomic Alterations in Gleason Score 10 Prostate Cancer Cancers DOI 10.3390/cancers17071055 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.4%
  3. 2025 Enhancing AI-based decision support system with automatic brain tumor segmentation for EGFR mutation classification Medical & Biological Engineering & Computing DOI 10.1007/s11517-025-03447-2 YÖKSİS SJR Q2 JCR Q2 OpenAlex 23.6%
  4. 2025 The G protein-coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells The FEBS Journal DOI 10.1111/febs.70099 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 93.9%
  5. 2025 Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer The Eurasian Journal of Medicine DOI 10.5152/eurasianjmed.2025.25804 YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex üst %10 OpenAlex 90.1%
  6. 2025 The G protein-coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells The FEBS Journal DOI 10.1111/febs.70099 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 93.9%
  7. 2025 Clinical Outcomes and Genomic Alterations in Gleason Score 10 Prostate Cancer Cancers DOI 10.3390/cancers17071055 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.4%
  8. 2025 Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer The Eurasian Journal of Medicine DOI 10.5152/eurasianjmed.2025.25804 YÖKSİS TR Index SJR Q3 OpenAlex üst %10 OpenAlex 90.1%
  9. 2024 Unveiling Off-Target Mutations in CRISPR Guide RNAs: Implications for Gene Region Specificity The CRISPR Journal DOI 10.1089/crispr.2024.0002 YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.5%
  10. 2024 Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours Journal of Neuro-Oncology DOI 10.1007/s11060-023-04556-4 YÖKSİS SJR Q1 JCR Q2 OpenAlex 84.3%
  11. 2024 Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells Journal of Interferon & Cytokine Research DOI 10.1089/jir.2023.0170 YÖKSİS SJR Q2 JCR Q4 OpenAlex 65.2%
  12. 2024 Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer Cancers DOI 10.3390/cancers16101871 YÖKSİS SJR Q1 JCR Q2 OpenAlex 54.5%
  13. 2024 Oral microbial dysbiosis in patients with oral cavity cancers Clinical Oral Investigations DOI 10.1007/s00784-024-05770-8 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.1%
  14. 2024 Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells Journal of Interferon & Cytokine Research DOI 10.1089/jir.2023.0170 YÖKSİS SJR Q2 JCR Q4 OpenAlex 65.2%
  15. 2024 Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations Cancers DOI 10.3390/cancers16071248 YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.5%
  16. 2024 Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer International Journal of Molecular Sciences DOI 10.3390/ijms25168913 YÖKSİS SJR Q1 JCR Q1 OpenAlex 48.7%
  17. 2024 Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer Cancers DOI 10.3390/cancers16101871 YÖKSİS SJR Q1 JCR Q2 OpenAlex 54.5%
  18. 2023 Expression analysis of novel long non-coding RNAs for invasive ductal and invasive lobular breast carcinoma cases Pathol Res Pract . DOI 10.1016/j.prp.2023.154391 YÖKSİS SJR Q2 JCR Q2 OpenAlex 48.8%
  19. 2023 Expression analysis of novel long non-coding RNAs for invasive ductal and invasive lobular breast carcinoma cases Pathol Res Pract . DOI 10.1016/j.prp.2023.154391 YÖKSİS SJR Q2 JCR Q2 OpenAlex 48.8%
  20. 2023 CHRM3-Associated miRNAs May Play a Role in Bile Acid-Induced Proliferation of H508 Colon Cancer Cells Turk J Gastroenterol DOI 10.5152/tjg.2022.22605 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 36.8%

Akademisyenlere dön